Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Interest Coverage Ratio (2016 - 2025)

Cytokinetics (CYTK) has disclosed Interest Coverage Ratio for 12 consecutive years, with 11.65 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio changed N/A to 11.65 in Q4 2025 year-over-year; TTM through Dec 2025 was 15.69, a N/A change, with the full-year FY2025 number at 13.43, up 5.56% from a year prior.
  • Interest Coverage Ratio was 11.65 for Q4 2025 at Cytokinetics, up from 15.77 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 3.87 in Q2 2022 to a low of 28.35 in Q1 2022.
  • A 5-year average of 14.82 and a median of 16.28 in 2021 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: tumbled 1375.55% in 2021, then surged 71.21% in 2022.
  • Cytokinetics' Interest Coverage Ratio stood at 5.15 in 2021, then tumbled by 249.83% to 18.0 in 2022, then rose by 1.19% to 17.79 in 2023, then grew by 11.33% to 15.77 in 2024, then grew by 26.15% to 11.65 in 2025.
  • Per Business Quant, the three most recent readings for CYTK's Interest Coverage Ratio are 11.65 (Q4 2025), 15.77 (Q3 2024), and 10.22 (Q2 2024).